BSB (BlockStreet) fluctuates 55.2% in 24 hours: speculative rebound driven by $92 million surge in trading volume
Bitget Pulse2026/05/09 16:02Brief Overview of Volatility
In the past 24 hours, the price of BSB rebounded from a low of $0.507 to a high of $0.78709, currently at $0.62815, with a fluctuation amplitude of 55.2%. The 24-hour trading volume surged to approximately $92 million (with some platform data at $85-92 million), significantly higher than the recent average levels.
Brief Analysis of Unusual Activity Causes
- Trading volume surged by more than $92 million, fueling a speculative rebound. Bitget Pulse reported on May 8 that this was the main driver.
- The price sharply rose from a low of $0.47128 to a high of $0.78709, accompanied by an increase in DEX trading volume, but there were no official announcements or partner events to confirm this movement.
Market Views and Outlook
The community’s prevailing sentiment is optimistic. Many posts on X discuss a 20%+ gain within an hour and pump potential. However, analysts warn of an overbought RSI (74), high funding rate (0.17%), and intensified selling pressure, indicating possible retracement risks. CMC data shows a current minor drop of 4.53%, and it is necessary to monitor whether the trading volume remains high in the short term.
Note: This analysis is generated automatically by AI based on public data and on-chain monitoring and is for informational purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin ETF inflows hit $381M – Could BTC end its August losing streak?
3 Top Altcoins Primed for a MEGA PUMP (ISO 20022 Compliant)
Rising Demand for Weight Loss Drugs Drives Eli Lilly's Q2 Revenue Up 48% Year-on-Year, Full-Year Revenue Guidance Raised to $85-87 Billion｜Earnings Report Insights
Eli Lilly's Q2 revenue reached $22.97 billion, a year-on-year increase of 48%. Adjusted EPS was significantly above expectations, and the company simultaneously raised its full-year guidance. Surging demand for weight loss and diabetes medications has made the GLP-1 business the core driver of growth, boosting profitability. With the advancement of next-generation weight loss therapies and the expansion of its innovative pipeline, Eli Lilly is accelerating the development of a diversified growth engine.
After a sharp drop, Sandisk (SNDK.US) rises for two consecutive days—can the financial report confirm the start of an AI storage comeback?
Judging from history, after SanDisk's financial report was released and the stock price plummeted, it seemed to provide a good opportunity for dip buyers.
Crypto prices
More
